Tawazun Health and LiverScan Group Announce Strategic Partnership to Expand High-Quality FibroScan® Services Across the UK
Tawazun Health and LiverScan are proud to announce a groundbreaking partnership aimed at transforming access to liver health diagnostics across the...
S6.6 – Remembering Stephen Harrison and His Many Contributions to MASH
On the first anniversary of Stephen Harrison's passing, we take an episode to remember our co-founder and colleague, Stephen Harrison, his...
S6.5.3 – Expert: Scott Friedman on Gene Therapy and Advances in Liver Science
This week’s expert, Hepatologist and Key Opinion Leader Scott Friedman, joins Roger to advances in acceptance of gene therapy and knowledge in other...
S6.5.2 – Newsmaker: Naga Chalasani on Real-World Experience Prescribing Resmetirom
This weekend’s Newsmaker, Indiana University hepatologist and key opinion leader Naga Chalasani, joins Roger Green to discuss Early Experience with...
S6.5.1 – Roundtable: FGF-21s and A Promising Future on Cirrhosis
This conversation is the opening segment of SurfingMASH’s April discussion of drug development in memory of Stephen A. Harrison. In addition to...
S6.5 – Drug Development Week: FGF-21s, Cirrhosis, Resmiterom, Gene Therapies
00:00:00 – Surf’s Up: Season 6 Episode 5 Host Roger Green briefly describes this episode’s three sections and introduces Roundtable guests. The...
S6.4.2 – Newsmaker: Fatty Liver Alliance Founder Mike Betel Discusses the Increased Visibility of Patient Advocates
This week's Newsmaker is Mike Betel, Founder of the Fatty Liver Alliance. He discusses some of the reasons that key MASLD Patient Advocates like...
S6.4.1 – MASLD Drugs, SLD Spectrum Insights Suggest Bright Future
Surfing the MASH Tsunami concludes its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on...
S6.4 – Reasons for Optimism in MASLD Drug Development and Patient Advocacy
Surfing the MASH Tsunami concludes its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on...
S6.3.3 – Expert: GLI’s Jeff McIntyre discusses implications of FDA job cuts on MASH Drugs
This week’s Expert is Jeff McIntyre, Vice President, Liver Programs at the Global Liver Institute. His major topic is how recent high-level FDA job...
S6.3.2 – Newsmakers: HistoIndex’s Yukti Choudhury Discuses Their New Product, FibroSIGHT
This week’s newsmaker, Yukti Choudhury, Director of Clinical Development at HistoIndex, joins Roger Green to discuss FibroSIGHT, a new HistoIndex...
S6.3.1 – Roundtable: Spotting Tomorrow’s Trends in Today’s MASLD Studies
Surfing the MASH Tsunami continues its coverage of the AASLD Emerging Trends Conference on MASLD, MetALD and ALD. This week, the panelists focus on...